Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | S100A4 | P26447 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | CDC25B | P30305 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL153656 | 1.00 | TDP1 (0.45) | TDP1ALOX15S100A4MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL584695 | 0.97 | ALOX15 (0.43) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL30447948 | 0.83 | TDP1 (0.65) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL266796 | 0.83 | TDP1 (0.65) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL29481018 | 0.67 | S100A4 (0.58) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL5712107 | 0.67 | S100A4 (0.58) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL16385020 | 0.66 | KDM4E (0.38) | TDP1ALOX15MAPK1KDM4EMAOA | |
| SCHEMBL3141116 | 0.65 | S100A4 (0.63) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL933891 | 0.65 | S100A4 (0.63) | TDP1ALOX15S100A4MEN1KMT2A | |
| SCHEMBL11875421 | 0.64 | MEN1 (0.61) | TDP1ALOX15S100A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735049-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | Beone Medicines I GmbH (CH) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735048-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | Beone Medicines I GmbH (CH) | 2026-05-06 | — | — | EP | disclosed |
| EP-4683672-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Beone Medicines I GmbH (CH) | 2026-01-28 | — | — | EP | disclosed |
| EP-4661913-A1 | SELF-STABILIZING LINKER CONJUGATES | Beone Medicines I GmbH (CH) | 2025-12-17 | — | — | EP | disclosed |
| EP-4642490-A1 | B7H3 ANTIBODY DRUG CONJUGATES | Beone Medicines I GmbH (CH) | 2025-11-05 | — | — | EP | disclosed |
| EP-4594327-A1 | LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, AND MEDICAL USE THEREOF | BeiGene Switzerland GmbH (CH) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025124456-A1 | ANTIBODY DRUG CONJUGATE PLATFORMS | BEIGENE, LTD. (KY) | 2025-06-19 | — | — | WO | disclosed |
| CN-119948031-A | Ligand-drug conjugates of isatecan analogs and medical uses thereof | 广州百济神州生物制药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-4536666-A1 | ANTIBODY DRUG CONJUGATES | BeiGene, Ltd. (KY) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025032555-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEIGENE SWITZERLAND GMBH (CH) | 2025-02-13 | — | — | WO | disclosed |
| WO-2025032556-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEIGENE SWITZERLAND GMBH (CH) | 2025-02-13 | — | — | WO | disclosed |
| CN-119317630-A | Antibody drug conjugates | 百济神州有限公司 | 2025-01-14 | — | — | CN | disclosed |
| WO-2025002368-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEIGENE, LTD. (GB) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025002370-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEIGENE, LTD. (GB) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024194851-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIGENE SWITZERLAND GMBH (CH) | 2024-09-26 | — | — | WO | disclosed |
| WO-2024165045-A1 | SELF-STABILIZING LINKER CONJUGATES | BEIGENE, LTD. (KY) | 2024-08-15 | — | — | WO | disclosed |
| CN-118450907-A | Antibody drug conjugates | 百济神州有限公司 | 2024-08-06 | — | — | CN | disclosed |
| WO-2024067811-A1 | LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, AND MEDICAL USE THEREOF | BEIGENE, LTD. (KY) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023237050-A1 | ANTIBODY DRUG CONJUGATES | BEIGENE, LTD. (KY) | 2023-12-14 | — | — | WO | disclosed |
| CN-106117213-B | Heteroaryl compounds and methods for their synthesis and purification | 西格诺药品有限公司 | 2022-03-18 | — | — | CN | disclosed |